+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • ID: 5311890
  • Report
  • April 2021
  • Region: Global
  • 140 pages
  • IMARC Group

FEATURED COMPANIES

  • Akorn Inc
  • Apotex Corp.
  • Endo International plc
  • Mallinckrodt
  • Mylan N.V.
  • Pfizer Inc
The global specialty generics market reached a value of US$ 57.3 Billion in 2020. Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don't require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc. Looking forward, the publisher expects the global specialty generics market to exhibit strong growth during the next five years.

This latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Report Scope:
  • Historical, Current and Future Market Trends
Market Breakup by Region:
  • North America
  • United States
  • Canada
  • Europe
  • Italy
  • Germany
  • Spain
  • United Kingdom
  • France
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa
Market Breakup by Route of Administration:
  • Injectables
  • Oral
  • Others
Market Breakup by Indication:
  • Oncology
  • Autoimmune Diseases
  • Infectious Diseases
  • Others
Market Breakup by Distribution channel:
  • Retail Pharmacies
  • Specialty Pharmacies
  • Hospital Pharmacies
Competitive Landscape:

The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

Key Questions Answered in This Report:
  • How has the global specialty generics market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global specialty generics industry?
  • What has been the impact of COVID-19 on the global specialty generics industry?
  • What is the breakup of the global specialty generics market based on the indication?
  • What is the breakup of the global specialty generics market based on the route of administration?
  • What is the breakup of the global specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the global specialty generics industry?
  • What are the key driving factors and challenges in the global specialty generics market?
  • What is the structure of the global specialty generics industry and who are the key players?
  • What is the degree of competition in the global specialty generics market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Akorn Inc
  • Apotex Corp.
  • Endo International plc
  • Mallinckrodt
  • Mylan N.V.
  • Pfizer Inc
1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors

7 Market Breakup by Route of Administration
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Indication
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast

9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 Market Overview
10.1.2 Market Performance
10.1.3 Market Breakup by Country
10.1.4 United States
10.1.4.1 Market Trends
10.1.4.2 Market Forecast
10.1.5 Canada
10.1.5.1 Market Trends
10.1.5.2 Market Forecast
10.2 Europe
10.2.1 Market Overview
10.2.2 Market Performance
10.2.3 Market Breakup by Country
10.2.4 Italy
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Germany
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 France
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 United Kingdom
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.2.8 Spain
10.2.8.1 Market Trends
10.2.8.2 Market Forecast
10.3 Asia Pacific
10.3.1 Market Overview
10.3.2 Market Performance
10.3.3 Market Breakup by Country
10.3.4 Japan
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 China
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 India
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 South Korea
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Market Overview
10.4.2 Market Performance
10.4.3 Market Breakup by Country
10.4.4 Brazil
10.4.4.1 Market Trends
10.4.4.2 Market Forecast
10.4.5 Mexico
10.4.5.1 Market Trends
10.4.5.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Overview
10.5.2 Market Performance
10.5.3 Market Forecast

11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 Teva Pharmaceuticals Industries
11.3.2 Akorn, Inc.
11.3.3 Mylan N.V.
11.3.4 Mallinckrodt
11.3.5 Sandoz International GmbH
11.3.6 Pfizer, Inc.
11.3.7 Sun Pharmaceutical Industries Ltd.
11.3.8 Valeant Pharmaceuticals
11.3.9 Apotex Corp.
11.3.10 Endo International plc.

List of Figures
Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2015-2020
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2020
Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2020
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2020
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2020
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 7: Global: Specialty Generics Industry: SWOT Analysis
Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
Figure 9: Global: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2015 & 2020
Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2015 & 2020
Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2015 & 2020
Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2015 & 2020
Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2015 & 2020
Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2015 & 2020
Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2015 & 2020
Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2021-2026
Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2015 & 2020
Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2021-2026
Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2015 & 2020
Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2021-2026
Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2015 & 2020
Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2021-2026
Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2020
Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables
Table 1: Global: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Specialty Generics Market Forecast: Breakup by Route of Administration (in Billion US$), 2021-2026
Table 3: Global: Specialty Generics Market Forecast: Breakup by Indication (in Billion US$), 2021-2026
Table 4: Global: Specialty Generics Market Forecast: Breakup by Distribution Channel (in Billion US$), 2021-2026
Table 5: Global: Specialty Generics Market Forecast: Breakup by Region (in Billion US$), 2021-2026
Table 6: North America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 7: Europe: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 8: Asia Pacific: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 9: Latin America: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 10: Middle East and Africa: Specialty Generics Market: Key Industry Highlights, 2020 and 2026
Table 11: Global: Specialty Generics Market Structure
Table 12: Global: Specialty Generics Market: Key Players
Note: Product cover images may vary from those shown
  • operating in the market are Teva Pharmaceuticals Industries
  • Akorn Inc
  • Mylan N.V.
  • Mallinckrodt
  • Sandoz International GmbH
  • Pfizer Inc
  • Sun Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals
  • Apotex Corp.
  • Endo International plc
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll